• news
    • Press releases
    • Blog
    • Media Coverage
    • Event
  • Documents
  • About
  • Team
  • funds
    • o2h human health KI EIS
    • o2h human health SEIS
    • o2h human health EIS
  • Portfolio
  • knowledgehub
    • what is KI EIS fund?
  • Contact

o2h-ventures

  • news
    • Press releases
    • Blog
    • Media Coverage
    • Event
  • Documents
  • About
  • Team
  • funds
    • o2h human health KI EIS
    • o2h human health SEIS
    • o2h human health EIS
  • Portfolio
  • knowledgehub
    • what is KI EIS fund?
  • Contact

Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment and you are unlikely to be protected if something goes wrong. Take 2 mins to learn more

o2h Ventures selected as finalist for best seed VC in UKBAA awards 2023
o2h Ventures selected as finalist for best seed VC in UKBAA awards 2023
Jun 14 2023

Cambridge, UK: o2h Ventures, a leading venture capital firm focused on seed stage investing into biotech therapeutics in the UK, is delighted to announce that it has been selected as a finalist for “Best Seed VC of the Year” by the prestigious UKBAA Angel Investment Awards 2023.

o2h Ventures is an early-stage biotech therapeutics fund that has seen many of its portfolio companies move into Series A and B investments, with three now moving through pivotal clinical studies in humans. We invests across the whole of the UK though 75% of its portfolio is based in Cambridge, UK. The team at o2h Ventures likes to be involved early and is either among the first investors or first institutional investors in 15 out of the 28 companies that they have invested in.

Sunil Shah, CEO at o2h Ventures, said, “Our qualification as a finalist for Best Seed VC by the UKBAA Awards is a testament to our passion for driving innovation in the biotech sector and supporting entrepreneurs on their path to success. We take immense pride in our role as a catalyst for groundbreaking ideas and are honored to be recognized by the UKBAA for our commitment to nurturing early-stage biotech companies to develop new biotech therapeutics.

The UKBAA Awards 2023 ceremony, scheduled for 6th July 2023, will bring together key industry leaders, investors, and entrepreneurs to celebrate the exceptional achievements of the venture capital community.

To find out more about the awards: https://awards.ukbaa.org.uk/

About UKBAA Angel Investment Awards

The annual UKBAA Angel Investment Awards celebrate high growth and success of the angel and early-stage investment market – recognising the fastest growing brands and acknowledging the founders, angels, crowd funders and early-stage venture capital investors behind them.

The Awards ceremony is taking place at the Science Museum, London on Thursday 6th July 2023 at 7pm, and will showcase the success & determination of the angel and early-stage investment community

Connect with us
  • linkedin
  • youtube
  • email
o2h-ventures
recent press releases
  • o2h-ventures o2h Ventures Makes SEIS investment in Sansanima, A University of Sheffield Spinout Developing Alternatives to Animal Testing 28 May 2025
  • o2h-ventures o2h Ventures Shortlisted for ‘Seed VC of the Year’ at UKBAA Angel Investment Awards 2025 14 May 2025
  • o2h-ventures o2h Ventures Backs Enedra Therapeutics, Targeting Complex Cancers 07 May 2025
o2h-ventures
o2h Ventures Limited
Hauxton House,
The Mill SciTech Park,
Mill Lane, Hauxton
Cambridge
CB22 5HX
07341612481
invest@o2h.com
about
  • about us
  • team
  • portfolio
  • funds
insights and news
  • knowledge hub
  • press releases
  • blog
  • event
  • documents
connect with us
  • linkedin
  • youtube
  • email
Please refer to the relevant fund’s full risk warnings contained in their Information Memorandums.
Your capital is at risk. Investing in early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. o2h Ventures’ funds are targeted exclusively at sophisticated or high net worth investors who understand these risks and make their own investment decisions. Tax relief depends on an individual’s circumstances and may change in the future. In addition, the availability of tax relief depends on the company invested in maintaining its qualifying status. Past performance is not a reliable indicator of future performance. You should not rely on any past performance as a guarantee of future investment performance.
o2h ventures Limited is regulated and authorised by the Financial Conduct Authority (FRN 812245). Capital at risk, only suitable for high net worth and sophisticated investors
© 2025 o2h ventures
  • Privacy Policy
  • Blog
  • Contact us

Risk Information

Due to the potential for losses, the Financial Conduct Authority (FCA) considers this investment to be high risk

What are the key risks?

1 – You could lose all the money you invest

• If the business you invest in fails, you are likely to lose 100% of the money you invest. Most start-up businesses fail.

2 – You are unlikely to be protected if something goes wrong

• Protection from the Financial Services Compensation Scheme (FSCS), in relation to claims against failed regulated firms, does not cover poor investment performance. Try the FSCS investment protection checker here. (https://www.fscs.org.uk/check/investment-protection-checker)

• Protection from the Financial Ombudsman Service (FOS) does not cover poor investment performance. If you have a complaint against an FCA-regulated firm, FOS may be able to consider it. Learn more about FOS protection here. (https://www.financial-ombudsman.org.uk/consumers)

3 – You won’t get your money back quickly

• Even if the business you invest in is successful, it may take several years to get your money back. You are unlikely to be able to sell your investment early.

• The most likely way to get your money back is if the business is bought by another business or lists its shares on an exchange such as the London Stock Exchange. These events are not common.

• If you are investing in a start-up business, you should not expect to get your money back through dividends. Start-up businesses rarely pay these.

4 – Don’t put all your eggs in one basket

• Putting all your money into a single business or type of investment for example, is risky. Spreading your money across different investments makes you less dependent on any one to do well.

• A good rule of thumb is not to invest more than 10% of your money in high-risk investments (https://www.fca.org.uk/investsmart/5-questions-ask-you-invest)

5 – The value of your investment can be reduced

• The percentage of the business that you own will decrease if the business issues more shares. This could mean that the value of your investment reduces, depending on how much the business grows. Most start-up businesses issue multiple rounds of shares.

• These new shares could have addition rights that your shares don’t have, such as the right to receive a fixed dividend, which could further reduce your chances of getting a return on your investment.

If you are interested in learning more about how to protect yourself, visit the FCA’s website here (https://www.fca.org.uk/investsmart)